INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $724,000 | -80.5% | 10,905 | -67.1% | 0.00% | -84.6% |
Q1 2019 | $3,711,000 | +988.3% | 33,175 | +1128.7% | 0.01% | +1200.0% |
Q3 2018 | $341,000 | +8.6% | 2,700 | -27.8% | 0.00% | 0.0% |
Q2 2018 | $314,000 | -44.9% | 3,740 | -61.9% | 0.00% | -66.7% |
Q3 2017 | $570,000 | +54.5% | 9,820 | +222.0% | 0.00% | +50.0% |
Q2 2017 | $369,000 | -29.4% | 3,050 | -34.1% | 0.00% | -33.3% |
Q1 2017 | $523,000 | +24.5% | 4,627 | +17.1% | 0.00% | 0.0% |
Q4 2016 | $420,000 | -46.1% | 3,952 | -16.5% | 0.00% | -40.0% |
Q3 2016 | $779,000 | +99.2% | 4,735 | +72.7% | 0.01% | +66.7% |
Q2 2016 | $391,000 | +11.4% | 2,741 | +0.2% | 0.00% | 0.0% |
Q1 2016 | $351,000 | +273.4% | 2,735 | +336.2% | 0.00% | +200.0% |
Q4 2015 | $94,000 | -85.8% | 627 | -84.3% | 0.00% | -83.3% |
Q3 2015 | $663,000 | +1200.0% | 4,000 | +2122.2% | 0.01% | – |
Q1 2015 | $51,000 | +325.0% | 180 | +125.0% | 0.00% | – |
Q4 2014 | $12,000 | 0.0% | 80 | +60.0% | 0.00% | – |
Q3 2014 | $12,000 | – | 50 | -75.0% | 0.00% | – |
Q2 2014 | $0 | -100.0% | 200 | -77.8% | 0.00% | – |
Q1 2014 | $7,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |